PubRank

P Sweny

Author PubWeight™ 86.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med 1983 2.07
2 Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet 1977 1.71
3 Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet 1980 1.60
4 Abdominal hernias in patients receiving continuous ambulatory peritoneal dialysis. Br Med J (Clin Res Ed) 1981 1.59
5 Post-renal transplant distal limb bone pain. An under-recognized complication of transplantation distinct from avascular necrosis of bone? Transplantation 1995 1.45
6 Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther 2007 1.45
7 Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet 1988 1.41
8 Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy. Nephrol Dial Transplant 1989 1.39
9 Cyclosporin-induced renal magnesium leak in renal transplant patients. Nephrol Dial Transplant 1990 1.38
10 Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis 2004 1.35
11 Sixteen months experience with cyclosporin-A in human kidney transplantation. Transplant Proc 1981 1.35
12 Atherosclerotic renovascular disease causing renal impairment--a case for treatment. Clin Nephrol 1989 1.28
13 Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J Gen Virol 1995 1.26
14 Rhabdomyolysis and systemic infection. Br Med J (Clin Res Ed) 1983 1.22
15 Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation. Am J Transplant 2008 1.19
16 Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG). J Med Virol 1999 1.19
17 Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation. J Med Virol 1997 1.15
18 Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft recipient. Br Med J (Clin Res Ed) 1982 1.13
19 Atrial thrombus and central venous dialysis catheters. Am J Kidney Dis 2001 1.11
20 Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet 1981 1.11
21 Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol 1998 1.09
22 Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Transplantation 2000 1.03
23 Phenytoin-induced pseudolymphoma. A report of a case and review of the literature. Br J Dermatol 1992 1.00
24 Rejection encephalopathy. Proc Eur Dial Transplant Assoc 1981 0.98
25 Renal physiology revisited: amiloride. Lancet 1986 0.98
26 Parathyroid hormone as a causative factor of primary non-function in renal transplants. Br Med J (Clin Res Ed) 1988 0.97
27 The effect of cyclosporin A on peripheral blood T cell subpopulations in renal allografts. Clin Exp Immunol 1982 0.96
28 Studies on long-term T-cell-mediated immunity to Epstein-BArr virus in immunosuppressed renal allograft recipients. Int J Cancer 1981 0.96
29 Captopril-enhanced 99mTc DTPA scintigraphy in the detection of renal-artery stenosis. Nephrol Dial Transplant 1988 0.96
30 Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration. J Antimicrob Chemother 1983 0.96
31 Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial. Kidney Int 2001 0.96
32 Acute tubular necrosis due to rhabdomyolysis and pancreatitis associated with Salmonella enteritidis food poisoning. Nephrol Dial Transplant 1993 0.94
33 Membranous glomerulonephritis and autoimmune thyroid disease. Clin Nephrol 1981 0.92
34 Gastrointestinal complications of dialysis related amyloidosis. BMJ 1988 0.91
35 Haemolytic-uraemic syndrome in recipients of bone marrow transplants not treated with cyclosporin A. Histopathology 1986 0.91
36 The safety and efficacy of MMF in lupus nephritis: a pilot study. Lupus 2001 0.90
37 Rejection encephalopathy. An acute neurological syndrome complicating renal transplantation. J Neurol Sci 1982 0.89
38 Three years' experience of continuous ambulatory peritoneal dialysis. Lancet 1981 0.89
39 Rejection encephalopathy. Lancet 1982 0.88
40 Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation? Bone Marrow Transplant 1988 0.88
41 Prognosis of critically-ill patients with acute renal failure: APACHE II score and other predictive factors. Q J Med 1989 0.88
42 Pregnancy in renal transplant recipients: the Royal Free Hospital experience. QJM 2003 0.87
43 Kaposi's sarcoma following renal transplantation. Int J Dermatol 1992 0.86
44 ACE inhibitors. Lancet 1988 0.85
45 Minimal-change glomerular nephritis. Normal kidneys in an abnormal environment? Transplantation 1994 0.85
46 Cyclosporine A enhances platelet aggregation. Kidney Int 1987 0.85
47 Can urinary thyroid hormone loss cause hypothyroidism? Lancet 1991 0.85
48 Double-blind, placebo-controlled trial of human lymphoblastoid interferon prophylaxis of cytomegalovirus infection in renal transplant recipients. Nephrol Dial Transplant 1992 0.84
49 Screening for renovascular disease with captopril-enhanced renography. Nephrol Dial Transplant 1992 0.84
50 Convulsions associated with cyclosporin A in renal transplant recipients. Br Med J (Clin Res Ed) 1985 0.83
51 How complete is a total parathyroidectomy in uraemia? Br Med J (Clin Res Ed) 1987 0.83
52 Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation. Transplantation 1995 0.82
53 The source of cytomegalovirus infection in seropositive renal allograft recipients is frequently the donor kidney. Transplant Proc 1987 0.82
54 The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure. Br J Clin Pharmacol 1992 0.82
55 Different patterns of endothelial cell activation in renal and pulmonary vascular disease in scleroderma. QJM 1998 0.82
56 Cerebral venous sinus thrombosis in minimal change nephrotic syndrome. Nephrol Dial Transplant 1995 0.81
57 The prognostic significance of positive CMV cultures during surveillance of renal transplant recipients. Transplantation 1993 0.81
58 Interpreting regulatory authority guidance on immunosuppressive therapy for renal transplantation: a response to the UK's National Institute for Clinical Excellence (NICE). Clin Nephrol 2008 0.81
59 Fenclofenac induced interstitial nephritis confirmed by inadvertent rechallenge. Br Med J (Clin Res Ed) 1985 0.81
60 The enhancing and sensitizing effects of donor blood components, including dendritic cells, in a rat renal allograft model. Transplantation 1984 0.80
61 Gallium-67 scintigraphy in the detection of infected polycystic kidneys in renal transplant recipients. Nucl Med Commun 1989 0.80
62 Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10. Tissue Antigens 2004 0.80
63 In vitro cyclosporine toxicity. The effect of verapamil. Transplantation 1989 0.80
64 Hyperlipidaemia in untreated nephrotic syndrome, increased production or decreased removal? Clin Chim Acta 1981 0.79
65 Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction. Kidney Int 2000 0.79
66 Successful therapeutic use of rituximab in refractory Wegener's granulomatosis after renal transplantation. Clin Nephrol 2007 0.79
67 Glomerulonephritis, thymoma and myasthenia gravis. Q J Med 1983 0.79
68 Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis. Br Med J (Clin Res Ed) 1986 0.79
69 Comparison of continuous arteriovenous haemofiltration and haemodialysis in acute renal failure. Lancet 1988 0.78
70 Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHI 621 in renal transplantation. Transplant Proc 1996 0.78
71 Heterogeneity of HLA-DR+ cells in normal human kidney. Immunohistological and cytochemical characterisation of discrete cell populations. J Clin Pathol 1983 0.78
72 Controlled trial of azathioprine and cyclosporin to prevent anti-HLA antibodies due to third-party transfusion. Nephrol Dial Transplant 1988 0.77
73 Donor-derived human herpes virus 8-related Kaposi's sarcoma in renal allograft ureter. Transpl Infect Dis 2007 0.77
74 Calcineurin inhibitors enhance low-density lipoprotein oxidation in transplant patients. Kidney Int Suppl 1999 0.77
75 Nephrotoxicity of ionic and non-ionic contrast material in digital vascular imaging and selective renal arteriography. Br J Radiol 1983 0.76
76 Plasmapheresis in the haemolytic-uraemic syndrome in children. Br Med J (Clin Res Ed) 1981 0.76
77 Cytokine nephropathy and multi-organ dysfunction in lymphoma. Nephrol Dial Transplant 1998 0.76
78 Acute renal failure occurring in scleroderma treated with cyclosporin A: a report of three cases. Br J Rheumatol 1994 0.76
79 Patients with atherosclerotic renovascular disease presenting to a renal unit: an audit of outcome. Postgrad Med J 1993 0.76
80 Pharmacokinetics and immunodynamics of chimeric IL-2 receptor monoclonal antibody SDZ CHI 621 in renal allograft recipients. Transpl Int 1996 0.76
81 Serum cholesterol falls spontaneously in nephrotic patients with progressive renal disease. Ren Fail 1993 0.76
82 Diuretic escape and rebound oedema in renal allograft recipients. Br Med J 1979 0.75
83 Antiviral treatment after solid organ transplantation. Lancet 2005 0.75
84 Angiotensin converting enzyme inhibitors and renal artery occlusion. BMJ 1989 0.75
85 Captopril in hypertension after renal transplantation. Postgrad Med J 1984 0.75
86 HIV infection in a long-term renal transplant recipient. Int J STD AIDS 1995 0.75
87 Nephrology, dialysis and transplantation. Postgrad Med J 1993 0.75
88 Nephrology, dialysis and transplantation. Postgrad Med J 1990 0.75
89 Lithium nephrotoxicity and red cell lithium. Nephrol Dial Transplant 1990 0.75
90 Digital vascular imaging and selective renin sampling in evaluation of vascular anatomy in renal transplant recipients. Br Med J (Clin Res Ed) 1983 0.75
91 Tests for renovascular disease. Lancet 1992 0.75
92 The clinical application of a rapid diagnostic test for the detection of cytomegalovirus infection in renal transplant recipients. Transplant Proc 1987 0.75
93 Comparison of oral and intravenous cyclosporine A in kidney transplants. Transplant Proc 1987 0.75
94 Induction of immunological unresponsiveness by multiple blood transfusion in uraemic patients. Lancet 1981 0.75
95 The use of captopril-DTPA scanning in the diagnosis of atherosclerotic renal artery stenosis in patients with impaired renal function. Am J Hypertens 1991 0.75
96 Calcium set point progressively worsens in hemodialysis patients despite conventional oral 1-alpha hydroxycholecalciferol supplementation. Clin Nephrol 1993 0.75
97 Measurement of glomerular filtration rate without blood sampling: validation in renal transplant patients. Br J Radiol 1984 0.75
98 Schistosomiasis in renal transplantation. Br J Urol 1982 0.75
99 Severe hypertension and childhood epilepsy in a 23-year-old Caucasian woman. Eur J Vasc Endovasc Surg 2000 0.75
100 Elective conversion of patients from cyclosporine to tacrolimus for hypertrichosis. Transplant Proc 1998 0.75
101 Renal transplantation after removal of anti-HLA antibodies. Lancet 1984 0.75
102 Investigating hypomagnesaemia. Lancet 1987 0.75
103 Blood cyclosporin concentrations and renal allograft dysfunction. Br Med J (Clin Res Ed) 1986 0.75
104 Epstein-Barr-virus-associated lymphoproliferation arising in a renal allograft. Nephron 1989 0.75
105 Conversion of stable renal allografts from CyA to azathioprine: a 5-year follow-up. Transplant Proc 1997 0.75
106 Renal transplant policy. Lancet 1981 0.75
107 Calycoureterostomy: a novel technique for post-renal transplant stricture. Surgeon 2004 0.75
108 Failure of sodium aurothiomalate and triethyl phosphine gold to cause renal tubular injury in rheumatoid arthritis: implications for the aetiology of gold-related nephropathy. Clin Rheumatol 1983 0.75
109 FK506 and CsA differ in their effect on intracellular cytokine expression following kidney transplantation. Transplant Proc 2001 0.75
110 Malignant melanoma in patient with renal transplant. Lancet 1980 0.75
111 Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults. Nephrol Dial Transplant 1988 0.75
112 Preliminary experience with cyclosporin A in human renal allografts. Transplant Proc 1980 0.75
113 Oxidizability of low-density lipoproteins from Neoral and tacrolimus-treated renal transplant patients. Transplant Proc 1998 0.75
114 Increased expression of Ia (HLA-DR) antigens in rejecting kidneys. Lancet 1984 0.75
115 How to measure cyclosporin. Lancet 1984 0.75
116 The reappearing kidney: an unusual complication of renal biopsy. Nephrol Dial Transplant 1999 0.75
117 Tuberculous peritonitis complicating peritoneal dialysis: a case for early diagnostic laparotomy? Nephrol Dial Transplant 1992 0.75
118 Cyclosporin inhibition of glucose transport in cell culture. Transplant Proc 1989 0.75
119 Ultraviolet light--denatured DNA/anti-ultraviolet light--denatured DNA immune-complex nephritis in rabbits. J Lab Clin Med 1980 0.75
120 The effects of vitamin A toxicity on calcium and lipid metabolism in chronic renal failure. Proc Eur Dial Transplant Assoc 1981 0.75
121 Successful renal transplantation with cadaveric donor kidneys of extremely prolonged cold ischaemic time. Nephrol Dial Transplant 1987 0.75
122 Indium-111 white blood cell scan for infectious complications of polycystic renal disease. J Nucl Med 1986 0.75
123 Cytomegalovirus matching in renal transplantation. Lancet 1988 0.75
124 Effects of low-density lipoproteins on mesangial cell growth and viability in vitro. Nephrol Dial Transplant 1990 0.75
125 An in vitro model of nephrocalcinosis using rabbit inner medullary collecting tubular cell culture. Biochem Biophys Res Commun 1989 0.75
126 Successful renal transplantation despite a positive fluorescence-activated cell sorter crossmatch following plasma exchange of donor-specific anti-HLA antibodies. Transplantation 1986 0.75
127 Lack of specialized antigen-presenting cells (IDCs) in donor heart, kidney, liver, and lung at transplantation. Transplant Proc 1989 0.75
128 Digital vascular imaging and selective renin sampling in post-transplant hypertension. Which kidney is responsible? Clin Nephrol 1983 0.75
129 The action of antidiuretic hormone on the renal collecting duct. Nephrol Dial Transplant 1988 0.75